There is a thread on HotCopper for PNV which is headed “the clinician’s speak”. There are an increasing number of positive studies and articles by clinicians about Novosorb BTM in the UK, US and India.

https://hotcopper.com.au/threads/the-clinicians-speak.6460688/page-15

There was also some excitement that the Newcastle upon Tyne hospitals NHS foundation trust bought £200,000 of BTM recently with a fairly enthusiastic ”legal justification”.

https://bidstats.uk/tenders/2024/W17/821166385

The collection of positive feedback accumulated by those who follow the company suggests that sales should continue to take off.

It also seems to be a product that can be mass produced at scale. My only niggle is there was mention in a recent co announcement and in DW’s podcast of a new distribution centre in Melbourne, and I do not know whether growth can be funded from cash generated and held.

Disc: held, dyor

I made the mistake of IRL trimming PNV during the week but I did have a lot of them.

they seem to just be getting started, they are growing at pace, recently profitable and seem to be able to scale rapidly.

the reference in recent announcements to having to pay for a distribution centre over the next couple of years caused me to rethink the capex.

but the co has got to $4 a few years ago and is in a much better position now. I would expect this to fly there fairly soon. But it didn’t stop me from trimming.

former hot stock, sales down in pandemic due to less people out and about getting burns injuries. 
38% growth 2H on 1H
small profit